MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)

Typically moves ±4.30% on earnings
EARNINGS ANALYTICS
event_note Approx. Next Earnings: ~2026-11-06 APPROXIMATE
search

Across 14 earnings reports since Mar 20, 2023, MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX) has a clear post-earnings pattern. It moves ±4.30% on average after reporting and finishes higher 42.9% of the time. Its largest post-earnings gain was +10.69% (May 11, 2026) and its largest decline was -15.02% (Feb 29, 2024). The next earnings report is predicted for 2026-11-06 (approximate).

Earnings reactions

How MLTX moved on each past earnings report.

Up Down

Earnings Impact

Total Earnings

14

Avg Abs. Movement

±4.30%

Positive %

42.9%

Negative %

57.1%

Historical Earnings Statistics

Date Timing Earnings move SEC Filing
Aug 10, 2026 ☀ PRE -4.82% open_in_new
May 11, 2026 ☀ PRE +10.69% open_in_new
Feb 23, 2026 ☀ PRE -0.53% open_in_new
Nov 05, 2025 ☀ PRE +4.59% open_in_new
event

Earnings Count

14

Total earnings in dataset

trending_up

Avg Abs. Movement

±4.30%

Avg % price change on earnings

description

SEC Filings

View

Browse all SEC filings

account_balance

Institutional ownership

Holdings as of Jun 30, 2026 · SEC 13-F

View all 15 →
15
Funds holding
$150834299
Total value held
Buying
10 added · 5 reduced
Janus Henderson Group Plc
$64303830 NEW BUY
Jpmorgan Chase & Co
$27603662 +27.37%
Blackrock, Inc.
$21315581 +7.14%
Bank Of America Corp /De/
$14639435 +3.74%
Morgan Stanley
$10973331 -8.28%

SEC Filing Types

Recent SEC Filings

10 most recent
Form Date Filed View on EDGAR
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G/A 20260814 open_in_new SEC.gov
SCHEDULE 13G 20260814 open_in_new SEC.gov
10-Q 20260810 open_in_new SEC.gov
8-K 20260810 open_in_new SEC.gov
S-3ASR 20260810 open_in_new SEC.gov
S-8 20260810 open_in_new SEC.gov
4 20260729 open_in_new SEC.gov
4 20260723 open_in_new SEC.gov
4 20260721 open_in_new SEC.gov

Frequently asked about MLTX earnings

When does MoonLake Immunotherapeutics Class A Ordinary Shares report earnings next? expand_more

MoonLake Immunotherapeutics Class A Ordinary Shares (MLTX)'s next earnings date is approximate for 2026-11-06. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.

How much does MLTX stock move after earnings? expand_more

Over 14 reports, MLTX has moved an average of ±4.30% the session after earnings, closing higher 42.9% of the time.

What was MLTX's biggest post-earnings move? expand_more

MLTX's largest post-earnings gain on record was +10.69% on May 11, 2026, and its largest decline was -15.02% on Feb 29, 2024.

Where can I find MoonLake Immunotherapeutics Class A Ordinary Shares's SEC filings? expand_more

All of MoonLake Immunotherapeutics Class A Ordinary Shares's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.

Sector peers